QA: Lexaria Bioscience Corp in us_pharma/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001348362_2018_Lexaria_Bioscience_Corp.pdf

Logs

warning The stock_price does not exist industry.us_generic {}
info NetIncome node detected by revenue/expenses heuristic input.sec.calculation_linkbase.edgar_model_mapping {'net_inc_node': 'IncomeLossFromContinuingOperations'}

Graph

Absolute values for 0001348362, Lexaria Bioscience Corp

  xvar xval
0 AssetsCurrent 2,795,495
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 1,856
3 remainder_Assets 62,827
4 LiabilitiesCurrent 92,347
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 12,314
9 ResearchAndDevelopmentExpense 34,231
10 remainder_Expenses 1,678,716
11 remainder_Revenues 178,235
12 remainder_NetIncome 0
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 2,860,178
1 Liabilities 92,347
2 Expenses 1,725,261
3 Revenues 178,235
4 StockholdersEquity 2,767,831
5 NetIncome -1,547,026
6 ComprehensiveNetIncome -1,547,026
7 BaseVar 2,428,010
8 EconomicCapitalRatiobeforeLimitedLiability 3.04
9 EconomicCapitalRatio 3.71

Edgar->Model Mapping

Feature Distribution

Change over Time